Literature DB >> 15292104

Preservation of testicular arteries during subinguinal microsurgical varicocelectomy: clinical considerations.

Ethan D Grober1, Jeanne O'brien, Keith A Jarvi, Armand Zini.   

Abstract

Microsurgical varicocelectomy with intentional preservation of the testicular artery(ies) is regarded as the gold standard approach to varicocele repair. We sought to determine whether the number of testicular arteries preserved at the time of micro-surgical varicocelectomy predicts improvement in postoperative semen parameters. We analyzed the records of 334 infertile men who underwent varicocelectomy performed by a single surgeon using a subinguinal microsurgical technique between July 1996 and January 2003. We examined the association between the number of testicular arteries preserved at the time of varicocelectomy and serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), varicocele grade, testicular volume, and postoperative improvement in semen parameters. Unilateral, left-sided varicocelectomy was performed in 194 men, while bilateral varicocelectomy was performed in 140 men. Mean (+/-SE) sperm concentration (20.1 +/- 1.5 x 10(6)/mL to 26.7 +/- 1.9 x 10(6)/mL, P =.001), percent motility (24.7 +/- 1.0% to 30.9 +/- 1.2%, P =.001), and percent normal morphology (35.8 +/- 1.4% to 37.7 +/- 1.5%, P =.046) improved significantly following varicocelectomy. The mean number of preserved testicular arteries was 1.5 on the left (range, 1-4) and 1.5 on the right (range, 1-4). The number of testicular arteries preserved at the time of varicocelectomy did not correlate significantly with preoperative assessment of serum FSH, LH, varicocele grade, and testicular volume or with postoperative improvement in semen parameters. Our data indicate that preoperative parameters are not predictive of the number of testicular arteries identified at the time of microsurgery. These data also suggest that the number of arteries identified and preserved with meticulous spermatic cord dissection does not correlate with improvement in semen parameters.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15292104     DOI: 10.1002/j.1939-4640.2004.tb02849.x

Source DB:  PubMed          Journal:  J Androl        ISSN: 0196-3635


  9 in total

1.  Dr. Zini's rebuttal.

Authors:  Armand Zini
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

2.  Varicocelectomy: microsurgical subinguinal technique is the treatment of choice.

Authors:  Armand Zini
Journal:  Can Urol Assoc J       Date:  2007-09       Impact factor: 1.862

3.  Male factor infertility: innovations in varicocele surgery.

Authors:  Joel Marmar
Journal:  Nat Rev Urol       Date:  2009-09       Impact factor: 14.432

4.  Editorial Comment: Use of indocyanine green angiography in microsurgical subinguinal varicocelectomy - lessons learned from our initial experience.

Authors:  Marcello Cocuzza
Journal:  Int Braz J Urol       Date:  2017 Sep-Oct       Impact factor: 1.541

5.  Macroscopic and microsurgical varicocelectomy: what's the intraoperative difference?

Authors:  Xiaopeng Liu; Hao Zhang; Xingxing Ruan; Hengjun Xiao; Wentao Huang; Liaoyuan Li; Xin Gao; Yan Zhang
Journal:  World J Urol       Date:  2012-09-22       Impact factor: 4.226

6.  Microsurgical intermediate subinguinal varicocelectomy.

Authors:  Joo Yong Lee; Ho Song Yu; Won Sik Ham; Dong Hyuk Kang; Kyu Hyun Kim; Doo Yong Chung; Kang Su Cho
Journal:  Int Surg       Date:  2014 Jul-Aug

7.  Outcome of Loupe-Assisted Sub-inguinal Varicocelectomy in Infertile Men.

Authors:  Selim S Abdelrahman; Bayoumy I Eassa
Journal:  Nephrourol Mon       Date:  2012-06-20

8.  Abnormal Human Sperm Parameters Contribute to Sperm DNA Fragmentation in Men with Varicocele.

Authors:  Yong Seog Park; Sun Hee Lee; Hye Won Choi; Hyo Serk Lee; Joong Shik Lee; Ju Tae Seo
Journal:  World J Mens Health       Date:  2018-07-30       Impact factor: 5.400

Review 9.  Extended indications for varicocelectomy.

Authors:  G Luke Machen; Jay I Sandlow
Journal:  F1000Res       Date:  2019-09-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.